Alector, Inc. Files 8-K: Material Agreement and Financial Disclosures

Ticker: ALEC · Form: 8-K · Filed: 2024-11-14T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation, regulation-fd

TL;DR

Alector filed an 8-K on Nov 14, 2024, reporting a material definitive agreement and financial disclosures.

AI Summary

On November 14, 2024, Alector, Inc. entered into a material definitive agreement, likely related to its financial obligations. The company also made a regulation FD disclosure and filed financial statements and exhibits. This filing indicates significant corporate activity and potential financial commitments for Alector.

Why It Matters

This filing signals a significant corporate event for Alector, Inc., potentially involving new financial obligations or strategic partnerships that could impact its future operations and financial standing.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement and financial obligations, which could introduce new risks or opportunities for the company.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Alector, Inc. on November 14, 2024?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.

What type of financial obligation is Alector, Inc. reporting?

Alector, Inc. is reporting the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement.

What is the significance of the Regulation FD Disclosure mentioned in the filing?

A Regulation FD Disclosure is made to prevent the selective disclosure of material nonpublic information to investors.

When was Alector, Inc. incorporated, and in which jurisdiction?

Alector, Inc. was incorporated in Delaware.

What is Alector, Inc.'s principal executive office address?

Alector, Inc.'s principal executive office is located at 131 Oyster Point Blvd., Suite 600, South San Francisco, California, 94080.

From the Filing

0000950170-24-127056.txt : 20241114 0000950170-24-127056.hdr.sgml : 20241114 20241114161009 ACCESSION NUMBER: 0000950170-24-127056 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20241114 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822933343 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38792 FILM NUMBER: 241462188 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 8-K 1 alec-20241114.htm 8-K 8-K false 0001653087 0001653087 2024-11-14 2024-11-14   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2024     Alector, Inc. (Exact name of Registrant as Specified in Its Charter)     Delaware 001-38792 82-2933343 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)           131 Oyster Point Blvd. Suite 600   South San Francisco , California   94080 (Address of Principal Executive Offices)   (Zip Code)   Registrant’s Telephone Number, Including Area Code: (415) 231-5660     (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock   ALEC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Item 1.01 Entry into a Material Definitive Agreement. On November 14, 2024 (the “Closing Date”), Alector, Inc., a Delaware corporation (the “Company”), and Alector LLC, a Delaware limited liability company, as co-borrower (together with the Company, the “Borrowers”), entered into a loan and security agreement (the “Loan Agreement”) by and among the Borrowers, the several banks and other financial institutions from time to time

View on Read The Filing